NCT01926496 2025-03-07
Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%
LEO Pharma
Phase 4 Completed
Clinical Trials
28 trialsNCT02406014 2025-02-24
Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp
LEO Pharma
Phase 4 Completed
NCT05741294 2025-02-20
A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses
Almirall, S.A.
Phase 4 Completed
NCT03327831 2024-06-27
Study of Daylight Photodynamic Therapy With Aminolevulinic Acid for Actinic Keratoses
University of California, Irvine
Phase 4 Completed
NCT05900258 2023-11-14
SunDamage
Medical University of Graz
Phase 4 Completed
NCT04875026 2022-09-19
Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial
Pierre Fabre Medicament
Phase 4 Completed
NCT02866695 2022-03-09
Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients
University of California, San Francisco
Phase 4 Completed
NCT00777127 2022-02-07
LEIDA
Viatris Inc.
Phase 4 Completed
NCT01453179 2022-02-07
LEIDA 2
Viatris Inc.
Phase 4 Completed
NCT04842422 2022-01-11
Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream
Medical University of Graz
Phase 4 Completed
NCT02984072 2021-03-09
MentholPDT
University of Dundee
Phase 4 Completed
NCT03511326 2021-02-18
SESAME 2
Galderma R&D
Phase 4 Completed
NCT02736760 2020-11-09
Daylight-PDT With MAL for AK and Photodamaged Skin
University Hospital Regensburg
Phase 4 Completed
NCT02990221 2019-09-24
Efficacy of Ingenol Mebutate on Actinic Keratoses and Field Cancerization vs Cryotherapy
University of Campania Luigi Vanvitelli
Phase 4 Completed
NCT02446223 2019-09-06
Evaluate the Efficacy and Safety of Large-Scale Field-Directed Topical Therapy of Actinic Keratosis of the Chest w/Ingenol Mebutate 0.015%
Goldman, Butterwick, Fitzpatrick and Groff
Phase 4 Completed
NCT03279328 2019-06-25
Evaluating Skin Appearance Following 5-Flourouracil Cream for Treatment of Actinic Keratosis and the Effects of Topical Agents
University of Arizona
Phase 4 Completed
NCT00695578 2018-12-31
Clinical Trial to Evaluate Biafine Cream Versus Standard Care in Subjects With Actinic Keratosis Post Cryotherapy
Wake Forest University Health Sciences
Phase 4 Completed
NCT03731988 2018-11-06
Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy According to the Laser Density for Actinic Keratosis
Dong-A University
Phase 4 Completed
NCT00696488 2018-09-10
Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population
Wake Forest University Health Sciences
Phase 4 Completed
NCT02716714 2018-04-18
Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis
Korea University
Phase 4 Completed
NCT02622594 2017-07-19
Bilateral Comparison of Treatment of Facial Actinic Keratoses Using Microneedling and Photodynamic Therapy With Aminolevulinic Acid and Blue Light Versus Photodynamic Therapy With Aminolevulinic Acid and Blue Light Using Two Incubation Times
Dermatology, Laser & Vein Specialists of the Carolinas
Phase 4 Completed
NCT02251652 2017-04-26
Safety and Efficacy of Ingenol Mebutate 0.05% Gel When Used After Cryotherapy in the Hypertrophic Actinic Keratoses
Icahn School of Medicine at Mount Sinai
Phase 4 Completed
NCT00774787 2016-11-07
Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses
Rigel Dermatology
Phase 4 Completed
NCT01935531 2016-03-31
Effects of Topical Diclofenac on Tumor Metabolism
University Hospital Regensburg
Phase 4 Completed
NCT00204542 2011-08-19
Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head
University Hospital Tuebingen
Phase 4 Completed
NCT00110682 2008-04-24
Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses
Derm Research @ 888 Inc.
Phase 4 Completed
NCT00377273 2008-04-10
An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses
Sanofi
Phase 4 Completed
NCT00115154 2007-02-19
Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands
Graceway Pharmaceuticals, LLC
Phase 4 Completed